NSN 6505-01-457-8137
Part Details | USP ERGOTAMINE TARTRATE AND CAFFEINE TABLETS
6505-01-457-8137
Alternate Parts: 1246081, 0682161, CAFERGOT SUPP. 5X2MG, CAFERGOT5SUPPO, 6505-01-457-8137, 01-457-8137, 6505014578137, 014578137
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | AUG 04, 1998 | 01-457-8137 | 34182 ( ERGOTAMINE TARTRATE AND CAFFEINE TABLETS, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-457-8137
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 1246081 | B6095 | ASSOCIATION PHARMACEUTIQUE BELGE |
| 0682161 | B6095 | ASSOCIATION PHARMACEUTIQUE BELGE |
| CAFERGOT SUPP. 5X2MG | B1049 | NOVARTIS PHARMA |
| CAFERGOT5SUPPO | 04549 | SANDOZ INC |
Technical Data | NSN 6505-01-457-8137
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB2.000 MILLIGRAMS ERGOTAMINE TARTRATE AND AB100.000 MILLIGRAMS CAFFEINE |
| SPECIAL FEATURES | USED IN TREATING MIGRAINE HEADACHES; SYMPATHOLYTIC DRUG; ADMINISTERED IN SUPPOSITORY FORM; 5 SUPPOSITORIES PR PKG; 1 SUPP PR WRAPPER; NON HABIT FORMING; CONSTRICTS BLOOD VESSELS IN HEAD; STIMULATES CENTRAL NERVOUS SYSTEM; NOT INTENDED FOR PROLONGED USE; DISCONTINUE GRADUALLY IF USING THIS DRUG 1 MONTH OR MORE; MAY CAUSE WITHDRAWAL SYMPTOMS SUCH AS HEADACHE, DROWSINESS, IRRITABILITY |
